Delivery Order SPE2DB22D2007-SPE2DB25FH8MU
- Not listed
- This federal contract award, valued at $1,063.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 5,000 unit vials of Thrombin-JMI, a medical product, with a performance period through April 2025. The award is not associated with a set-aside program and represents an open competition contract. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
- The Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $1,852.50 to provide 4,563,816,290 units of THROMBIN-JMI 20,000 unit vials. The contract has a completion date of March 1, 2024 and was awarded on February 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation indicated. This delivery order is issued under an existing...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) as a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract covers the delivery of 20,000 unit vials of Thrombin-JMI, a specialty pharmaceutical product, to support military healthcare programs. The award has a firm fixed price of $6,410.56 and a completion date of July 8, 2024. No set-aside designation was...
- This federal contract award, valued at $5,928.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 contract vehicle that enables efficient procurement of essential pharmaceutical and medical supplies for military healthcare programs globally. The contract covers the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, the Corporate Office Division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract, valued at $4,180.74, is for the delivery of 5,000 unit vials of the drug Thrombin-JMI, a topical hemostatic agent used to control bleeding. The contract is a firm fixed price, full and open competition award with no set-aside designation....
- This federal contract award is for the delivery of THROMBIN-JMI 20,000 UNIT VIALS to the Defense Logistics Agency (DLA), a major defense agency responsible for logistics support to the U.S. military. The contract was awarded to Amerisourcebergen Drug Corp, a large pharmaceutical distribution company, on September 22, 2023 with a ceiling value of $6,595.68 and a completion date of September 25, 2023. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation,...
- This federal contract award (SPE2DB20D3103|SPE2DB24FM2M5) was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,470.00 firm fixed-price delivery order is for the supply of 20,000 unit vials of Thrombin-JMI, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trombrin-JMI 20,000 unit vials. The contract has a firm fixed price of $3,339.96 and an ultimate completion date of June 21, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 and running through November 2026. The IDC serves as the...
- <p>Amerisourcebergen Drug Corp has been awarded a six hundred forty-seven dollar firm fixed price delivery order against an unspecified government-wide acquisition contract by the Defense Logistics Agency. The delivery order is for five thousand units of Thrombin-JMI five thousand units vials with an anticipated completion date of October 19, 2023. Performance will take place in Conshohocken, Pennsylvania. No set-aside designation was applied to this award.</p>
- This federal contract award is for the delivery of Trombolin-JMI 20,000 unit vials to the Defense Logistics Agency (DLA). The $6,159.04 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a period of performance through March 27, 2023 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FH8MUDelivery Order
This is a single federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of 20,000 unit vials of the pharmaceutical product Thrombin-JMI, with a ceiling value of $4,801.44 and a completion date of January 27, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation indicated. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 1/24/25 |